Skeleton Technologies Appoints Dr. Hermann Schenk as Chief Operating Officer
Radeburg, Germany, February 03, 2015 --(PR.com)-- Skeleton Technologies, the leading European developer of ultracapacitors for motorsport, transport and industrial applications, has appointed Dr. Hermann Schenk as Chief Operating Officer. Dr. Schenk will be responsible for the company’s day-to-day activities, including overseeing the development of Skeleton Technologies’ manufacturing facility in Saxony, Germany.
Commenting on his new role, Dr Schenk said: “The ultracapacitor market has been growing rapidly in recent years and Skeleton Technologies’ industry-leading products have attracted very high interest. I am looking forward to taking the single largest breakthrough in ultracapacitor technology from the high-end segments to the mass market.”
Dr. Schenk has over 20 years experience in the high-tech sector, combining a background in research with over a decade in executive positions. He has a proven track record of scaling high-yield manufacturing in the chemical and semiconductor industries. Dr. Schenk has a PhD in theoretical physics from the University of Bonn.
As Founder and CEO of Covion Organic Semiconductors GmbH he led the company to a successful exit to Merck KGaA. He was CEO of Freiberger Compound Materials GmbH, a global market leader in III/V-semiconductors, where he successfully guided the company through a challenging transition period. Dr. Schenk was also Director of New Business Development at Merck OLED Materials.
“Having shown over ten times output increase in 2014, Skeleton Technologies is now ready to scale-up to highly automated manufacturing and further develop our operations in Saxony, Germany,” explained Taavi Madiberk, CEO of Skeleton Technologies. “Dr. Schenk brings a high level of understanding of novel manufacturing concepts and broad experience from German manufacturing powerhouses including Merck.”
Oliver Ahlberg, who is one of the founders of Skeleton Technologies and who has held the role of Chief Operating Officer prior to Dr. Schenk’s appointment, will take up the position of General Manager and lead the company’s operations in Estonia.
About Skeleton Technologies
Skeleton Technologies is the leading European developer and manufacturer of ultracapacitor cells, modules and engineering solutions for energy efficiency in transportation, industrial, renewable energy, defence and space applications.
Skeleton Technologies manufactures SkelCap™ ultracapacitor cells and SkelMod™ modules. SkelCap™ ultracapacitor cells are available in ranges from 250F to 3500F.
Skeleton Technologies is located in Bautzen, Germany and Viimsi, Estonia. The company employs 30 people and is rapidly growing.
For more information see http://www.skeletontech.com
Commenting on his new role, Dr Schenk said: “The ultracapacitor market has been growing rapidly in recent years and Skeleton Technologies’ industry-leading products have attracted very high interest. I am looking forward to taking the single largest breakthrough in ultracapacitor technology from the high-end segments to the mass market.”
Dr. Schenk has over 20 years experience in the high-tech sector, combining a background in research with over a decade in executive positions. He has a proven track record of scaling high-yield manufacturing in the chemical and semiconductor industries. Dr. Schenk has a PhD in theoretical physics from the University of Bonn.
As Founder and CEO of Covion Organic Semiconductors GmbH he led the company to a successful exit to Merck KGaA. He was CEO of Freiberger Compound Materials GmbH, a global market leader in III/V-semiconductors, where he successfully guided the company through a challenging transition period. Dr. Schenk was also Director of New Business Development at Merck OLED Materials.
“Having shown over ten times output increase in 2014, Skeleton Technologies is now ready to scale-up to highly automated manufacturing and further develop our operations in Saxony, Germany,” explained Taavi Madiberk, CEO of Skeleton Technologies. “Dr. Schenk brings a high level of understanding of novel manufacturing concepts and broad experience from German manufacturing powerhouses including Merck.”
Oliver Ahlberg, who is one of the founders of Skeleton Technologies and who has held the role of Chief Operating Officer prior to Dr. Schenk’s appointment, will take up the position of General Manager and lead the company’s operations in Estonia.
About Skeleton Technologies
Skeleton Technologies is the leading European developer and manufacturer of ultracapacitor cells, modules and engineering solutions for energy efficiency in transportation, industrial, renewable energy, defence and space applications.
Skeleton Technologies manufactures SkelCap™ ultracapacitor cells and SkelMod™ modules. SkelCap™ ultracapacitor cells are available in ranges from 250F to 3500F.
Skeleton Technologies is located in Bautzen, Germany and Viimsi, Estonia. The company employs 30 people and is rapidly growing.
For more information see http://www.skeletontech.com
Contact
Skeleton Technologies
Taavi Madiberk
+37253542387
www.skeletontech.com
Taavi Madiberk
+37253542387
www.skeletontech.com
Contact
Categories